Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Speciality: Oncology


Speaker:

Dr. Vineet Govinda Gupta ( Moderator ) | Senior Consultant Medical Oncologist

Dr. Atul Sharma ( Panelist ) | Senior Consultant Medical Oncologist, Jaypee Hospital, Noida

Dr. Abhishek Bansal ( Panelist ) | Consultant Medical Oncologist, SSB Heart And Multispeciality Hospital, Fridabad.

Description:

A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.

The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.

The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.

Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.

Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

Interleukin-6 may boost prediction of obesity-related cancers

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot